Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin A Delivery Routes for Refractory Epiphora
NCT01282541Phase 2Completed
- Start
- Feb 2011
- Primary completion
- Sep 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of botulinum toxin type A in epiphora (2 arms). Primary endpoint: Comparison of 1-minute Schirmer's test with and without anesthesia at 24 weeks. Started Feb 2011; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
epiphora
Beyond the preview
Go deeper on NCT01282541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01282541.